Name : anti-BRCA2 Antibody
Supplier : BLUEGEN ANTIBODIES
Price :465
SKU : GEN7879694693
| The antibodie's description | anti-Breast cancer type 2 susceptibility protein antibody |
| The antigen used | rat Breast cancer type 2 susceptibility protein antigen, epitope of the human |
| Gene name | Breast cancer type 2 susceptibility protein |
| Reactivity | rat, human |
| Research field | Cancer/Apoptosis |
| Related products | BRCA2 rabbit polyclonal antibodies |
| Description | Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bluegen antibodies they should be stored frozen at - 24° |
| Gene target | BRCA2 |
| Short name | anti-BRCA2 Antibody |
| Technique | antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name | early onset (Antibody to), antibody to-breast cancer 2 |
| Alternative technique | antibodies |
| Alternative to gene target | BRCA2 and IDBG-22703 and ENSG00000139618 and 675, BRCA2 and IDBG-630223 and ENSBTAG00000000988 and, BRCC2 and BROVCA2 and FACD and FAD and FAD1 and FANCD and FANCD1 and GLM3 and PNCA2, Brca2 and IDBG-209587 and ENSMUSG00000041147 and 12190, DNA-templated and biological process this GO :0045931 and positive regulation of mitotic cell cycle and biological process this GO :0048478 and replication fork protection and biological process this GO :0051276 and chromosome organization and biological process this GO :0051298 and centrosome duplication and biological process, early onset, gamma-tubulin binding, nuclei, signal transduction by p53 class mediator resulting in transcription of p21 class mediator and biological process this GO :0007141 and male meiosis I and biological process this GO :0007283 and spermatogenesis and biological process this GO :0007420 and brain development and biological process this GO :0007569 and cell aging and biological process this GO :0008283 and cell proliferation and biological process this GO :0008585 and female this GO nad development and biological process this GO :0008630 and intrinsic apoptotic signaling pathway in response to DNA damage and biological process this GO :0010165 and response to X-ray and biological process this GO :0010225 and response to UV-C and biological process this GO :0010332 and response to gamma radiation and biological process this GO :0010484 and H3 histone acetyltransferase activity and molecular function this GO :0010485 and H4 histone acetyltransferase activity and molecular function this GO :0030097 and hemopoiesis and biological process this GO :0030141 and secretory granule and cellular component this GO :0032465 and regulation of cytokinesis and biological process this GO :0033593 and BRCA2-MAGE-D1 complex and cellular component this GO :0033600 and negative regulation of mammary gland epithelial cell proliferation and biological process this GO :0042771 and intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator and biological process this GO :0043009 and chordate embryonic development and biological process this GO :0043015 and gamma-tubulin binding and molecular function this GO :0043234 and protein complex and cellular component this GO :0043966 and histone H3 acetylation and biological process this GO :0043967 and histone H4 acetylation and biological process this GO :0045893 and positive regulation of transcription, this GO :0000724 and double-strand break repair via homolo this GO us recombination and biological process this GO :0000910 and cytokinesis and biological process this GO :0001556 and oocyte maturation and biological process this GO :0001833 and inner cell mass cell proliferation and biological process this GO :0002020 and protease binding and molecular function this GO :0003697 and single-stranded DNA binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005813 and centrosome and cellular component this GO :0006281 and DNA repair and biological process this GO :0006289 and nucleotide-excision repair and biological process this GO :0006302 and double-strand break repair and biological process this GO :0006974 and cellular response to DNA damage stimulus and biological process this GO :0006978 and DNA damage response, this GO :0002020: protease binding, this GO :0002020: protease binding and also this GO :0003697: single-stranded DNA binding and also this GO :0005515: protein binding and also this GO :0010484: H3 histone acetyltransferase activity and also this GO :0010485: H4 histone acetyltransferase activity and also this GO :0043015: gamma-tubulin binding, this GO :0003697: single-stranded DNA binding, this GO :0005515: protein binding, this GO :0010484: H3 histone acetyltransferase activity, this GO :0010485: H4 histone acetyltransferase activity, this GO :0043015: gamma-tubulin binding, breast cancer 2 |
| Identity | 1101 |
| Gene | BRCA2 |
| Long gene name | BRCA2, DNA repair associated |
| Synonyms gene | FANCD1 FACD FANCD |
| Synonyms gene name | Fanconi anemia, complementation group D1 breast cancer 2, early onset breast cancer 2 |
| Synonyms | FAD FAD1 BRCC2 XRCC11 |
| Synonyms name | BRCA1/BRCA2-containing complex, subunit 2 |
| Locus | 13q13, 1 |
| Discovery year | 1994-10-17 |
| GenBank acession | U43746 |
| Entrez gene record | 675 |
| Pubmed identfication | 8091231 7581463 15057823 |
| RefSeq identity | NM_000059 |
| Classification | Fanconi anemia complementation groups |
| Havana BLAST/BLAT | OTTHUMG00000017411 |
| Locus Specific Databases | Breast Cancer Fanconi Anaemia Mutation Database BRCA1 database at LOVD-China LOVD - Leiden Open Variation Database LOVD - Leiden Open Variation Database Fanconi anemia database LRG_293 |